Novo Nordisk Pharmatech is the leading worldwide supplier of products such as recombinant insulin for cell growth media, and pharmaceuticalgrade quaternary ammonium compounds (quats) for the pharmaceutical and personal-care industries. These are manufactured to cGMP standards and, in both product areas, the company has distinguished itself for:
Novo Nordisk Pharmatech's quality system meets DS/EN ISO 9001 as well as ICH Guide Q7 for active pharmaceutical ingredients. In-process samples and finished products are carefully analysed in a modern, well-equipped laboratory. Fast, reliable services in documentation, analysis and manufacturing - as well as the ability to meet or exceed local and international regulatory requirements - have been key to securing customer satisfaction.
The company's delivery and stock policy is designed to meet the most demanding and urgent requirements of its customers, and pharmaceutical products can be shipped within a week. Many products are offered in a variety of packing solutions, meeting demands for small and large packaging.
Novo Nordisk Pharmatech aims to be the best supplier of insulin for cell culture processes by providing excellence at every step of the supply chain - beginning with the quality of its insulin, which is sourced directly from Novo Nordisk, the world's largest producer. Its recombinant insulin is a key component in serum-free growth media for mammalian cells. It is used for the manufacturing of monoclonal antibodies, virus vaccines, gene therapy products and many other biological drug products approved by regulatory bodies worldwide, including FDA and EMA.
Novo Nordisk Pharmatech is a reliable partner in helping customers find the right quality ingredients for their projects, even tailoring ingredients to match specific application needs. The company lives up to the highest-quality standards, providing pure, efficacious and safe products. Its entire supply chain, manufacturing processes and quality control take place in Denmark.
An innovative synthesis process makes Novo Nordisk Pharmatech a leading supplier of crystalline quats for a wide range of applications. High levels of purity for products such as benzalkonium chloride, cetrimide, cetrimonium bromide (CTAB) and others make them particularly suited for pharmaceutical applications such as vaccine production. They act as preservatives or active ingredients in many ophthalmic, nasal, oral and topical drugs, and in a variety of solutions, ointments and creams. Because Novo Nordisk Pharmatech's closely controlled production process keeps batch variation to a minimum, its quats are also in demand by the diagnostic reagent sector.
Novo Nordisk Pharmatech experts can advise customers about the right product for their formulation or develop a custom-designed product to meet specific needs. The company adheres to the latest European guidelines on good distribution practice and all quats are manufactured in accordance with the cGMP Guide ICH Q7 for active pharmaceutical ingredients, the highest available standard. Quality analyses are made according to multicompendial pharmacopoeias (BP, PhEur, USP/NF and JP) and are part of the regulatory documentation ensuring global compliance.
Novo Nordisk is a member of the UN Global Compact and World Business Council for Sustainable Development. As a fully owned subsidiary, Novo Nordisk Pharmatech follows the same general policies for sustainability, business ethics and code of conduct. The company manages its business in accordance with the 'triple bottom line' business principle, conducting activities in a financially, environmentally and socially responsible way.